<DOC>
	<DOCNO>NCT00264212</DOCNO>
	<brief_summary>To compare antihypertensive efficacy tolerability irbesartan irbesartan-hydrochlorothiazide fixed combination therapy amlodipine amlodipine plus hydrochlorothiazide treatment isolate systolic hypertension .</brief_summary>
	<brief_title>AMISH : Aprovel Management Isolated Systolic Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Main criterion list hereafter : Screening Outpatients With newly diagnose untreated OR previously diagnose , treat uncontrolled Isolated Systolic Hypertension define : seat Systolic Blood Pressure ( SBP ) ≥ 160mmHg &lt; 220 mmHg [ 160220 [ AND seat Diastolic Blood Pressure ( DBP ) &lt; 90 mmHg Randomization Having complete 2 4week washout/placebo runin phase Still eligible Blood Pressure seat SBP ≥ 160mmHg &lt; 220 mmHg [ 160220 [ AND seat DBP &lt; 90 mmHg . Exclusion Criteria ( Screening ) : Participation clinical trial within previous 3 month Patients history irbesartan , amlodipine , hydrochlorothiazide sensitivity define irbesartan , amlodipine , hydrochlorothiazide discontinuation due medically significant adverse effect Patients currently previously treat Angiotensin II Receptor Blocker ( irbesartan , losartan , candesartan , valsartan , telmisartan , etc . ) dihydropiridine Calcium Channel Blocker ( amlodipine , nicardipine , felodipine , nifedipine , etc . ) AND respond despite maximum tolerated dose Known suspect secondary hypertension ( e.g. , coarctation aorta , renovascular stenosis , etc . ) Known single functional kidney History recent myocardial infarction , coronary artery bypass graft surgery percutaneous transluminal coronary angioplasty , cerebrovascular accident ( Transient Ischaemic Attack , stroke ) within last 6 month study entry Patients know gastrointestinal , renal , hepatic , endocrine , cardiovascular , pulmonary , immunological hematological disease opinion investigator active uncontrolled Patients significant renal ( clearance creatinine &lt; 30 mL/mn ) , hepatic cardiac insufficiency , know valvular heart disease Serum potassium &lt; 3.5 mmol/L ( mEq/L ) &gt; 5.5 mmol/L ( mEq/L ) Presence clinically significant ventricular supraventricular arrhythmia , second third degree atrioventricular block , QTc prolongation ( Bazett &gt; 450 msec . ) ECG Pregnancy lactation . Women child bear potential ( postmenopausal ) use reliable contraceptive method The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>